# Course of well-being and mental health in Switzerland during the COVID-19 pandemic: results of a national survey within the framework of the COH-FIT study

**Authors:** Christian G. Huber, Janina Billian, Tiziana Ziltener, Philippe Conus, Roland von Känel, Gregor Hasler, Jihed Sehli, Anna Mosina, Damir Krinitski, Erich Seifritz, Eva Kowalinski, Isabelle Gothuey, Jennifer Marian, Undine E. Lang, Trevor Thompson, Marco Solmi, Christoph U. Correll, Sabina C. Heuss, Andres R. Schneeberger

PMC · DOI: 10.3389/fpsyt.2025.1642325 · Frontiers in Psychiatry · 2026-02-16

## TL;DR

This study shows how the mental health of the Swiss population declined during the COVID-19 pandemic, with lasting effects and regional differences.

## Contribution

The study provides a detailed, longitudinal analysis of mental health and well-being in Switzerland across three pandemic waves.

## Key findings

- Well-being scores dropped significantly during the pandemic, with the largest decline in the third wave.
- Mental health burden increased during the first wave and remained high without recovery in later waves.
- Regions like Ticino and Lake Geneva experienced the most severe mental health impacts.

## Abstract

The COVID-19 pandemic significantly impacted the mental health of the Swiss population.

This study analyzed data from the Collaborative Outcome study on Health and Functioning during Infection Times (COH-FIT) across three pandemic waves: T1 (April–June 2020), T2 (July–December 2020) or T3 (January–June 2021). Each participant participated only once, during one of these three waves. Participants reported their subjective well-being and mental health status for the two weeks prior to the pandemic (pre-pandemic baseline) and during their respective pandemic wave. Subjective well-being was assessed using the World Health Organization Well-Being Index (WHO-5) from 4,037 participants, while mental health was measured via the P-score, completed by 3,375 participants. The WHO-5 ranges from 0 to 100, with higher scores indicating better well-being, while the P-score also ranges from 0 to 100 whereas higher scores represent greater levels of perceived burden across five domains of mental health. Pre- and intra-pandemic differences were analyzed using Wilcoxon tests and ANOVA, with subgroup analyses across seven Swiss regions utilizing the Kruskal-Wallis test.

Participants had a mean age of 45.6 years (61.9% female). Results showed a substantial decline in well-being during the pandemic, with average WHO-5 scores decreasing from 75.3 pre-pandemic, to 66.5 during the first wave, 69.1 during the second, and 65.1 during the third, representing relative reductions of 11.7%, 8.2%, and 13.5%. The percentage of participants at risk for depression (WHO-5 <50) peaked during the third wave at 19.8%, up from 10.0% pre-pandemic. Mental health burden, as measured by the P-score, increased significantly during the first wave (from 20.6 to 27.3, +32.5%), and remained elevated across the two subsequent waves, with no significant recovery observed. Wilcoxon tests indicated significant differences between pre-pandemic and intra-pandemic WHO-5 and P-scores, with the largest effect sizes during the third wave (r = 0.652 for WHO-5; r = 0.487 for P-score). ANOVA showed significant intra-pandemic differences in WHO-5 across waves (p < 0.001), with improvements noted in the second wave. However, no intra-pandemic differences in P-scores were found (p = 0.298). Regional analyses revealed that Ticino, the Lake Geneva region, and Northwestern Switzerland experienced the most pronounced declines in well-being and increases in mental health burden. In contrast, Espace Mittelland and Eastern Switzerland experienced a less severe impact.

Overall, these findings highlight the considerable and lasting impact of COVID-19 on mental health in Switzerland, emphasizing the need for targeted interventions, particularly in the most affected regions.

## Linked entities

- **Diseases:** depression (MONDO:0002050)

## Full-text entities

- **Genes:** PC (pyruvate carboxylase) [NCBI Gene 5091] {aka PCB}
- **Diseases:** PTSD (MESH:D013313), mental distress (MESH:D012128), DSM-IV major depression (MESH:D003865), mental health problems (MESH:D000076082), mental illness (MESH:D001523), anxiety (MESH:D001007), depression (MESH:D003866), psychosis (MESH:D011618), COVID-19 (MESH:D000086382), Infection (MESH:D007239), Mental health (OMIM:603663), hallucinations (MESH:D006212), delusions (MESH:D063726), deaths (MESH:D003643)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950789/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12950789/full.md

## References

63 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950789/full.md

---
Source: https://tomesphere.com/paper/PMC12950789